Manufacturing technology

Our therapeutic candidates are manufactured on the CliniMACS Prodigy® platform an automated, closed system that has pioneered scalable cell therapy manufacturing. This means:

Consistency: reduced operator variability for reliable therapeutic products

Scalability: capacity to expand supply as needs grow

Quality assurance: processes designed to meet global GMP standards

Efficiency: supports faster scale up and helps optimize vein-to-vein time

By manufacturing our therapies on Miltenyi Biotec's CliniMACS Prodigy®, Miltenyi Biomedicine ensures robust process integrity and the infrastructure to deliver cell therapies to more patients reliably.